Lebanon Plan Commission on Monday night unanimously approved a design plan for Eli Lilly and Co.’s $4.5 billion center for advanced manufacturing and drug development at the LEAP Research and ...

A new study led by researchers from Boston University Chobanian & Avedisian School of Medicine has found there is no consensus in how clinical experts interpret CGM reports from people without ...

Greg Maynard of the Boston Policy Institute says Boston isn't taking the same steps as other communities to ensure more ...

Cynthia Cassell, a former U.S. Fulbright student scholar, says the Bidirectional Training Initiative will improve Lima ...

They also discovered that cigarette use declined among a subgroup of smokers in the study, lending weight to the hypothesis ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don't just curb their desire to eat; for some, they also lead them to drink ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

Lilly will provide an initial payment to complete a Phase I trial of OLX75016, which started in February 2024.

A few notable health care deals along with M&A in the AI-adjacent and reshoring themes occurred in January. Read more here.

Background Intravenous iron therapy with ferric derisomaltose (FDI) has been shown to improve outcomes in patients with heart ...

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...

Eli Lilly has begun the week with a bang. Early Monday morning, AdvanCell and OliX Pharmaceuticals put out news that the Big ...